Botfet / Company detail

TMDX

universe

TransMedics Group, Inc.

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic10.9%

Gross Margin59.9%

Revenue Cagr111.5%

Fcf Conversion70.2%

Fcf Yield5.4%

Interest Coverage10.8x

Market Cap B$2.5B

Pe16.0

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener